Literature DB >> 20963421

Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men.

Sean A Martin1, Matthew T Haren, Villis R Marshall, Kylie Lange, Gary A Wittert.   

Abstract

PURPOSE: To determine the prevalence of, and associated risk factors for, voiding and storage lower urinary tract symptoms (LUTS) in a population-based sample of Australian men.
METHODS: Data were collected from 1,103 men randomly selected, community-dwelling men, as part of the Florey Adelaide Male Ageing Study, after exclusion of men with prostate or bladder cancer or prior surgery to either organ. The presence of LUTS was assessed using the International Prostate Symptom Score. Urine flow was measured via flow meter. Demographic, clinical, and bio-psychosocial data were collected by questionnaire.
RESULTS: The prevalence of total, storage, and voiding LUTS was 18.1, 28.0 and 12.6%, respectively. The most common storage symptoms were frequency (12.3%), nocturia (9.9%) and urgency (8.1%), and voiding symptoms were weak stream (8.5%), intermittency (5.4%), incomplete emptying (5.1%) and straining (2.4%). There were linear associations between storage LUTS and increased abdominal fat mass, plasma glucose and low HDL cholesterol (components of the metabolic syndrome), obstructive sleep apnoea (OSA) risk, and retirement. Voiding symptoms were associated with a previous diagnosis of benign prostatic enlargement (BPH), mean peak urine flow, total energy intake, elevated risk of OSA, erectile dysfunction, physician-diagnosed thyroid dysfunction and higher household income.
CONCLUSIONS: The close association of storage LUTS with the metabolic syndrome, and of both storage and voiding LUTS with OSA, suggest that these conditions should be considered in men presenting with LUTS.

Entities:  

Mesh:

Year:  2010        PMID: 20963421     DOI: 10.1007/s00345-010-0605-8

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  29 in total

1.  Continuous positive airway pressure reduces nocturia in patients with obstructive sleep apnea.

Authors:  David Margel; Tamar Shochat; Ofir Getzler; Pinhas M Livne; Giora Pillar
Journal:  Urology       Date:  2006-04-25       Impact factor: 2.649

2.  Troublesome lower urinary tract symptoms in the community: a prevalence study.

Authors:  C Pinnock; V R Marshall
Journal:  Med J Aust       Date:  1997-07-21       Impact factor: 7.738

3.  Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia.

Authors:  Sadao Suzuki; Elizabeth A Platz; Ichiro Kawachi; Walter C Willett; Edward Giovannucci
Journal:  Am J Clin Nutr       Date:  2002-04       Impact factor: 7.045

Review 4.  Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

Authors:  Raymond C Rosen; Francois Giuliano; Culley C Carson
Journal:  Eur Urol       Date:  2005-01-05       Impact factor: 20.096

5.  The prevalence of lower urinary tract symptoms in Austrian males and associations with sociodemographic variables.

Authors:  G Haidinger; S Madersbacher; T Waldhoer; G Lunglmayr; C Vutuc
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

Review 6.  The relationship between erectile dysfunction and lower urinary tract symptoms and the role of phosphodiesterase type 5 inhibitors.

Authors:  Tobias S Köhler; Kevin T McVary
Journal:  Eur Urol       Date:  2008-09-04       Impact factor: 20.096

7.  Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia.

Authors:  Steven Lehrer; Edward J Diamond; Nelson N Stone; Michael J Droller; Richard G Stock
Journal:  J Urol       Date:  2002-12       Impact factor: 7.450

Review 8.  Afferent nerve regulation of bladder function in health and disease.

Authors:  William C de Groat; Naoki Yoshimura
Journal:  Handb Exp Pharmacol       Date:  2009

9.  Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

Authors:  Raymond Rosen; Jens Altwein; Peter Boyle; Roger S Kirby; B Lukacs; Eric Meuleman; Michael P O'Leary; Paolo Puppo; Chris Robertson; Francois Giuliano
Journal:  Eur Urol       Date:  2003-12       Impact factor: 20.096

Review 10.  Lower urinary tract symptoms and erectile dysfunction: epidemiology and treatment in the aging man.

Authors:  Shane Russell; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 2.862

View more
  32 in total

1.  Thulium laser VapoResection of the prostate versus traditional transurethral resection of the prostate or transurethral plasmakinetic resection of prostate for benign prostatic obstruction: a systematic review and meta-analysis.

Authors:  Zheng Deng; Menghao Sun; Yiping Zhu; Jian Zhuo; Fujun Zhao; Shujie Xia; Bangmin Han; Thomas R W Herrmann
Journal:  World J Urol       Date:  2018-04-12       Impact factor: 4.226

2.  Alterations in peripheral purinergic and muscarinic signaling of rat bladder after long-term fructose-induced metabolic syndrome.

Authors:  Shiu-Dong Chung; Chiang-Ting Chien; Hong-Jeng Yu
Journal:  Eur J Nutr       Date:  2012-03-18       Impact factor: 5.614

Review 3.  Review of Current Literature for Prostatic Artery Embolization.

Authors:  Hyeon Yu; Ari J Isaacson; Charles T Burke
Journal:  Semin Intervent Radiol       Date:  2016-09       Impact factor: 1.513

4.  Are blood vessels a target to treat lower urinary tract dysfunction?

Authors:  Martin C Michel; Russ Chess-Williams; Sharath S Hegde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-05-31       Impact factor: 3.000

5.  The effect of hypercholesterolemia on carbachol-induced contractions of the detrusor smooth muscle in rats: increased role of L-type Ca2+ channels.

Authors:  Zeynep Dicle Balkanci; Bilge Pehlivanoğlu; Sibel Bayrak; Ismail Karabulut; Serkan Karaismailoğlu; Ayşen Erdem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-08-07       Impact factor: 3.000

6.  Intake of caffeinated, carbonated, or citrus beverage types and development of lower urinary tract symptoms in men and women.

Authors:  Nancy N Maserejian; Carrie G Wager; Edward L Giovannucci; Teresa M Curto; Kevin T McVary; John B McKinlay
Journal:  Am J Epidemiol       Date:  2013-05-30       Impact factor: 4.897

Review 7.  Current Treatment for Benign Prostatic Hyperplasia.

Authors:  Arkadiusz Miernik; Christian Gratzke
Journal:  Dtsch Arztebl Int       Date:  2020-12-04       Impact factor: 5.594

Review 8.  The placebo and nocebo effects in functional urology.

Authors:  Hadi Mostafaei; Sandra Jilch; Greta Lisa Carlin; Keiichiro Mori; Fahad Quhal; Benjamin Pradere; Ekaterina Laukhtina; Victor M Schuettfort; Abdulmajeed Aydh; Reza Sari Motlagh; Claus G Roehrborn; Shahrokh F Shariat; Sakineh Hajebrahimi
Journal:  Nat Rev Urol       Date:  2021-12-23       Impact factor: 14.432

Review 9.  New therapeutic strategies for the treatment of male lower urinary tract symptoms.

Authors:  Konstantinos Dimitropoulos; Stavros Gravas
Journal:  Res Rep Urol       Date:  2016-04-26

10.  Premature ejaculation in patients with lower urinary tract symptoms: a systematic review.

Authors:  Retta Catherina Sihotang; Timotius Alvonico; Akmal Taher; Ponco Birowo; Nur Rasyid; Widi Atmoko
Journal:  Int J Impot Res       Date:  2020-05-11       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.